These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8391952

  • 1. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
    Maini RN, Brennan FM, Williams R, Chu CQ, Cope AP, Gibbons D, Elliott M, Feldmann M.
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S173-5. PubMed ID: 8391952
    [Abstract] [Full Text] [Related]

  • 2. Targeting TNF alpha for the therapy of rheumatoid arthritis.
    Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M.
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S63-6. PubMed ID: 7768056
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA).
    Maini RN, Elliott MJ, Brennan FM, Feldmann M.
    Clin Exp Immunol; 1995 Aug; 101(2):207-12. PubMed ID: 7648705
    [Abstract] [Full Text] [Related]

  • 4. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis.
    Camussi G, Lupia E.
    Drugs; 1998 May; 55(5):613-20. PubMed ID: 9585859
    [Abstract] [Full Text] [Related]

  • 5. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
    Deleuran BW, Chu CQ, Field M, Brennan FM, Mitchell T, Feldmann M, Maini RN.
    Arthritis Rheum; 1992 Oct; 35(10):1170-8. PubMed ID: 1329775
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
    Maini RN, Elliott MJ, Brennan FM, Williams RO, Chu CQ, Paleolog E, Charles PJ, Taylor PC, Feldmann M.
    Immunol Rev; 1995 Apr; 144():195-223. PubMed ID: 7590814
    [Abstract] [Full Text] [Related]

  • 7. New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis.
    Breedveld F.
    Eur Cytokine Netw; 1998 Sep; 9(3):233-8. PubMed ID: 9831171
    [Abstract] [Full Text] [Related]

  • 8. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
    Gao IK, Scholz P, Boehme MW, Norden C, Lemmel EM.
    Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
    [Abstract] [Full Text] [Related]

  • 9. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA, Helsen MM, Saxne T, van De Loo FA, Heinegard D, van Den Berg WB.
    J Immunol; 1999 Nov 01; 163(9):5049-55. PubMed ID: 10528210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC, Martel-Pelletier J, Pelletier JP.
    Biorheology; 2002 Nov 01; 39(1-2):237-46. PubMed ID: 12082286
    [Abstract] [Full Text] [Related]

  • 12. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
    Williams RO, Feldmann M, Maini RN.
    Proc Natl Acad Sci U S A; 1992 Oct 15; 89(20):9784-8. PubMed ID: 1409699
    [Abstract] [Full Text] [Related]

  • 13. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM, Feldmann M, Di Padova F, Brennan FM.
    Eur Cytokine Netw; 1994 Oct 15; 5(5):441-8. PubMed ID: 7880974
    [Abstract] [Full Text] [Related]

  • 14. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H.
    Z Rheumatol; 1995 Oct 15; 54(3):158-64. PubMed ID: 7660686
    [Abstract] [Full Text] [Related]

  • 15. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
    Tanaka Y.
    Rinsho Byori; 2008 Apr 15; 56(4):309-15. PubMed ID: 18516965
    [Abstract] [Full Text] [Related]

  • 16. The role of cytokines in the pathogenesis of rheumatoid arthritis.
    Feldmann M, Maini RN.
    Rheumatology (Oxford); 1999 Nov 15; 38 Suppl 2():3-7. PubMed ID: 10646481
    [Abstract] [Full Text] [Related]

  • 17. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
    Feldmann M, Brennan FM, Williams RO, Elliott MJ, Maini RN.
    J Inflamm; 1999 Nov 15; 47(1-2):90-6. PubMed ID: 8913935
    [Abstract] [Full Text] [Related]

  • 18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Nov 15; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 19. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M, Brennan FM, Elliott M, Katsikis P, Maini RN.
    Circ Shock; 1994 Aug 15; 43(4):179-84. PubMed ID: 7895323
    [Abstract] [Full Text] [Related]

  • 20. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE, Tetlow LC.
    Arthritis Res; 2000 Aug 15; 2(1):65-74. PubMed ID: 11219391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.